Best Practice & Research Clinical Haematology

Papers
(The TQCC of Best Practice & Research Clinical Haematology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19 disease and immune dysregulation36
Immunologic effects on the haematopoietic stem cell in marrow failure25
CD33 directed bispecific antibodies in acute myeloid leukemia20
The promise of macrophage directed checkpoint inhibitors in myeloid malignancies20
Immune checkpoint inhibitors in acute myeloid leukemia19
COVID-19 and antiphospholipid antibodies18
Perspectives on current survival and new developments in AML17
Treatment of telomeropathies17
Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax16
Congenital amegakaryocytic thrombocytopenia – Not a single disease14
COVID-19 and HSCT (Hematopoietic stem cell transplant)14
TCR gene-engineered cell therapy for solid tumors14
CD123 bi-specific antibodies in development in AML: What do we know so far?13
Distinguishing constitutional from acquired bone marrow failure in the hematology clinic13
Blood coagulation and cancer genes12
Have any strategies in Ph-like ALL been shown to be effective?12
Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome12
Management of patients with higher-risk myelodysplastic syndromes after failure of hypomethylating agents: What is on the horizon?12
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia11
New targets for CAR T therapy in hematologic malignancies11
Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage11
Toxicities associated with adoptive cellular therapies10
Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia10
Mechanisms of thrombosis in pancreatic ductal adenocarcinoma10
Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults10
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults10
Somatic mosaicism in inherited bone marrow failure syndromes10
Thrombosis and bleeding in hematological malignancy10
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?8
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?8
GATA2 and marrow failure8
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents8
Antibody based therapy in relapsed acute lymphoblastic leukemia7
Overcoming graft failure after haploidentical transplantation: Is this a possibility?7
Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults7
Clinical experience of CAR T cells for multiple myeloma7
Vaccine-induced immune thrombotic thrombocytopenia7
Clonal hematopoiesis and bone marrow failure syndromes6
Measurable residual disease in acute lymphoblastic leukemia: How low is low enough?6
How old is too old for a transplant?6
Can venetoclax-based therapy replace 7+3 induction in fit older adults with AML?5
Challenges in anticoagulation for patients with brain tumors5
Diagnosis and management of rare paediatric Non-Hodgkin lymphoma5
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care5
Accelerated and blast phase myeloproliferative neoplasms5
Coagulopathy in COVID-19 and anticoagulation clinical trials5
Marrow failure and aging: The role of “Inflammaging”5
Dysregulation of Protein S in COVID-195
Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL)5
Advances in CAR design5
Changing trends in the therapy of acute myeloid leukemia5
Myeloproliferative neoplasms in adolescents and young adults5
Bone marrow transplantation for acquired aplastic anemia: What's new5
0.025622129440308